PPD’s X-Chem signs multi-target collaboration with Janssen
PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.
Archives for January 12, 2015
Crown expands Precos site to build caucasian cancer expertise
Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.
WuXi jumps into genomic analysis, bioinformatics with $65m acquisition
Chinese service provider WuXi PharmaTech has acquired NextCODE Health, a US and Icelandic genomic analysis and bioinformatics company, for $65m in cash.
FDA blocks Australia site from importing tainted Cialis as Lilly claims innocence
The US FDA has published an import alert for an Australian manufacturing site of Eli Lilly after the agency found that its Cialis pills were tainted with the active ingredient of another popular ED (erectile dysfunction) drug -- Pfizer’s Viagra.
US FDA approves Impax’s Parkinson’s disease treatment following resolved manufacturing issues
Almost two years since it was first rejected, Impax Pharmaceuticals said late last week that the US FDA has approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease.
Judge rules Mylan monopoly suit against Celgene can continue
Mylan lawsuit accusing Celgene of using REMS to block generic Revlimid and Thalomid should go to trial says US Court.
EMA orphan approval hike reflects biology advances and pharma economics says expert
The record number of orphan drugs approved in Europe last year reflects the pharma industry’s need to refill pipelines and scientific advances says Genetic Alliance UK
Shire takes $5bn gamble on NPS' hormone replacement PDUFA decision
Shire says its $5.2bn (€4.4bn) acquisition of NPS Pharmaceuticals is a calculated risk, coming just days before the US FDA decides whther to approve the hormone replacement therapy Natpara.
Capsugel buys ionic liquid tech IP to enhance lipid-based drug solubility
Capsugel has acquired a technology platform which uses ionic liquids to enhance the solubility of lipid-based drug delivery systems.